Pancreatitis: correcting CFTR expression and function as a promising effective treatment
Paramita Sarkar, Wei-Yin Lin, Ava Movahed Abtahi, Woo Young Chung, Shmuel Muallem · 2026
Read Pancreatitis: correcting CFTR expression and function as a promising effective treatment by Paramita Sarkar, Wei-Yin Lin, Ava Movahed Abtahi, Woo Young Chung, Shmuel Muallem (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13175858.txt.
Introduction
Paramita Sarkar and co-authors argued for fixing a channel in pancreatitis in two thousand twenty-six. The pancreas makes enzymes and a protective alkaline fluid. Duct cells secrete that fluid to flush enzymes safely. A channel called CFTR is the critical step in secretion. Its failure appears across all pancreatitis forms. The review gathers evidence for restoring its function.
Acute and chronic forms share duct injury patterns. Without the channel, enzymes can activate inside the gland. That self-digestion drives pain and damage. Correcting channel expression could protect the duct. The authors call this a promising treatment direction. Existing channel drugs from cystic fibrosis inform the idea. Trials in pancreatitis are the proposed next step.
Catalog record
| CREATOR | Paramita Sarkar, Wei-Yin Lin, Ava Movahed Abtahi, Woo Young Chung, Shmuel Muallem |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Pancreatitis: correcting CFTR expression and function as a promising effective treatment Authors: Paramita Sarkar, Wei-Yin Lin, Ava Movahed Abtahi, Woo Young Chung, Shmuel Muallem Published: 2026 ABSTRACT The two principal cell types of the exocrine pancreas, acinar and ductal cells, serve distinct but complementary roles. Acinar cells synthesize and secrete digestive enzymes, whereas duct cells secrete fluid and bicarbonate (HCO3-). Ductal secretion protects the pancreas by producing an alkaline fluid that prevents premature digestive enzyme activation and facilitates their transport to the intestine. A critical step in this protective mechanism is protein kinase A–mediated activation of the luminal Cl- channel, cystic fibrosis transmembrane conductance regulator (CFTR). In this context, increasing evidence indicates that impaired CFTR function represents a common pathological feature across all forms of pancreatitis, the most prevalent disease of the exocrine pancreas. Acute and chronic pancreatitis are inflammatory disorders characterized by pancreatic ductal injury that initiates recurrent inflammatory episodes and subsequent acinar cell damage, for which effective treatments remain lacking. Accordingly, this review aims to summarize current evidence supporting alterations in CFTR expression and activity as key events in pancreatitis pathogenesis. Furthermore, given the availability of safe and effective CFTR correctors and potentiators currently approved for the treatment of cystic fibrosis, we argue that these agents warrant strong consideration as potential therapeutic strategies for pancreatitis. Introduction The human pancreas secretes approximately 2 liters per day of a highly alkaline fluid that transports digestive enzymes to the intestine. Acinar cells synthesize and secrete these digestive enzymes, which are initially released into isotonic fluid with a near-neutral pH. Pancreatic ductal cells are responsible for secreting the majority of the fluid of pancreatic juice (Lee et al., 2012, 2021). A key function of the ductal epithelium is the absorption of chloride (Cl-) ions and their exchange for bicarbonate (HCO3-), a process that increases the HCO3- concentration of pancreatic juice to levels exceeding 140 mM (Shin et al., 2020). HCO3- is the principal biological buffer and plays essential roles in pH regulation across all tissues. In the pancreas, however, HCO3- serves additional specialized functions, including neutralization of gastric acid, prevention of premature activation of digestive enzymes during their transit to the intestine, and establishment of an optimal intestinal pH for digestive enzyme activity (Lee et al., 2012). Moreover, as a chaotropic molecule, HCO3- facilitates the secretion and solubilization of macromolecules such as digestive enzymes and mucins in biological fluids (Hatefi and Hanstein, 1969; Quinton, 2010). Pancreatic enzyme, fluid, and HCO3- secretion are highly regulated processes that are initiated in response to food intake. The digestive response begins with neurohumoral stimulation of enzyme secretion from acinar cells. Activation of Ca²+-mobilizing Gq-coupled receptors (GPCRs), most notably muscarinic type 3 receptors (M3R), leads to an increase in cytoplasmic free Ca²+ concentration ([Ca²+]i) (Petersen and Tepikin, 2008; Ahuja et al., 2020). The Ca²+-dependent signaling is synergistically potentiated by cyclic adenosine monophosphate (cAMP) signaling, amplifying the secretory response (Williams, 2019; Ahuja et al., 2020). In parallel, ductal fluid and HCO3- secretion is predominantly stimulated by the hormone secretin acting through Gs-coupled receptors that elevate intracellular cAMP level (Lee et al., 2012; Pallagi et al., 2015). Ca²+ signaling downstream of M3 and other Gq-coupled receptors further synergizes with the cAMP-dependent pathway to generate a coordinated physiological ductal secretory response (Park et al., 2013; Hong et al., 2014; Luscher et al., 2020). Beyond these primary regulatory mechanisms, pancreatic secretion is finely tuned by additional modulatory factors released under various physiological conditions, including insulin, somatostatin, purines, and prostaglandins (Gardner and Jensen, 1986; Chandra, 2015). The essential role of pancreatic HCO3- secretion in maintaining pancreatic health is highlighted by cystic fibrosis, in which pancreatic damage is among the earliest manifestations of the disease (Durie, 2000). In addition, impaired HCO3- secretion has been reported in multiple forms of pancreatitis (Balazs and Hegyi, 2015; Pallagi et al., 2015; Zeng et al., 2017). To better understand the contribution of pancreatic ducts and CFTR to the initiation and progression of acute and chronic pancreatitis, it is therefore critical to elucidate the molecular mechanisms that mediates ductal HCO3- secretion. Comprehensive discussions of pancreatic fluid and HCO3- secretion and their regulation are available in a recent review (Lee et al., 2021), along with molecular insights into the role of STIM1-mediated ER/PM junctions in the regulation of anoctamin 1 (ANO1) (Lin et al., 2025) and CFTR (Sarkar et al., 2025). Here, we summarize the key features of ductal fluid and HCO3- secretion. Ductal fluid and HCO3- secretion Pancreatic fluid and HCO3- secretion is a tightly coupled, vectorial process mediated by the coordinated activity of basolateral and luminal HCO3- transporters. Over the past two decades, molecular, cellular, and physiological studies have identified the key ductal transporters and elucidated their properties and regulatory mechanisms, as summarized in Figure 1. The energy driving ductal secretion is provided by the Na+ and K+ gradients generated by the basolateral 3Na+/2K+-ATPase. The Na+ gradient fuels Na+-coupled transporters, whereas K+ channels establish a negative membrane potential that supports electrogenic transporters. HCO3- secretion is initiated by basolateral HCO3- uptake, which occurs predominantly via the electrogenic 1Na+–2HCO3- cotransporter NBCe1-B (SLC4A4) (Zhao et al., 1994; Abuladze et al., 1998; Boron et al., 2009). In addition, basolateral pH homeostasis is maintained by the Na+/H+ exchanger NHE1 (SLC9A1) (Lee et al., 2000) and the Cl-/HCO3- exchanger AE2 (SLC4A2) (Roussa et al., 2001). By extruding cytoplasmic H+, NHE1 contributes approximately 25% of basolateral HCO3- influx (Lee et al., 2012), while AE2 plays a critical role in maintaining intracellular Cl- required to sustain HCO3- secretion. Another basolateral Cl- and HCO3- transporter is the Ca²+-activated channel Bestrophin 2 (Best2) (Qu and Hartzell, 2008; Yu et al., 2010; Zhang et al., 2010), which is permeable to both anions (Qu and Hartzell, 2008). In the colon, Best2 mediates HCO3- influx (Yu et al., 2010); however, its function in pancreatic ducts remains unclear. Best2 may correspond to the basolateral Ca²+-activated Cl- channel proposed to mediate the “push–pull” model of Cl- transport in pancreatic acinar and duct cells (Kasai and Augustine, 1990). A model of ductal fluid and HCO3- secretion. The model summarizes the principal basolateral (highlighted in lower right) and luminal (highlighted in upper right) transporters that mediate ductal fluid and HCO3- secretion. HCO3- enters epithelial cells primarily through the basolateral, electrogenic 1Na+–2HCO3- cotransporter NBCe1-B, with additional influx mediated by the electroneutral Na+/H+ exchanger NHE1. The Cl-/HCO3- channel Best2 likely also contribute to basolateral HCO3- uptake and facilitate clearance of cytoplasmic Cl-. HCO3- subsequently exits across the luminal membrane mainly via the CFTR-regulated, electrogenic 1Cl-/2HCO3- exchanger SLC26A6, while CFTR primarily functions to recycle Cl-. Under conditions of low luminal and intracellular Cl- concentrations, residual HCO3- is secreted directly through CFTR following an increase in its HCO3- permeability. Most luminal Cl- is reabsorbed and is likely extruded across the basolateral membrane through Best2. The electrogenic basolateral and luminal HCO3- transporters NBCe1-B and SLC26A6, respectively, mediate net osmolyte transport which, together with paracellular Na+ flow from the basolateral to the luminal side, drives transepithelial water secretion. Basolateral HCO3- influx is followed by HCO3- efflux across the apical membrane, which is mediated by coordinated physical and functional interactions between the cAMP-activated Cl- channel CFTR (Csanady et al., 2019) and the electrogenic 1Cl-/2HCO3- exchanger SLC26A6 (Shcheynikov et al., 2006; Wang